Moors & Cabot’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $245K | Hold |
1,161
| – | – | 0.01% | 792 |
|
|
2025
Q4 | $239K | Sell |
1,161
-411
| -26% | -$77.3K | 0.01% | 794 |
|
|
2025
Q3 | $247K | Sell |
1,572
-305
| -16% | -$47.1K | 0.01% | 758 |
|
|
2025
Q2 | $315K | Hold |
1,877
| – | – | 0.01% | 635 |
|
|
2025
Q1 | $259K | Sell |
1,877
-599
| -24% | -$76.4K | 0.01% | 692 |
|
|
2024
Q4 | $293K | Buy |
2,476
+70
| +3% | +$8.17K | 0.01% | 669 |
|
|
2024
Q3 | $266K | Sell |
2,406
-717
| -23% | -$75K | 0.01% | 695 |
|
|
2024
Q2 | $307K | Sell |
3,123
-3,177
| -50% | -$324K | 0.02% | 619 |
|
|
2024
Q1 | $705K | Buy |
6,300
+655
| +12% | +$70.7K | 0.04% | 392 |
|
|
2023
Q4 | $569K | Buy |
5,645
+363
| +7% | +$36K | 0.04% | 424 |
|
|
2023
Q3 | $459K | Buy |
5,282
+307
| +6% | +$27.8K | 0.03% | 463 |
|
|
2023
Q2 | $470K | Buy |
4,975
+73
| +1% | +$6.17K | 0.03% | 462 |
|
|
2023
Q1 | $370K | Buy |
4,902
+27
| +0.6% | +$2.04K | 0.03% | 533 |
|
|
2022
Q4 | $375K | Sell |
4,875
-885
| -15% | -$67.2K | 0.03% | 508 |
|
|
2022
Q3 | $384K | Sell |
5,760
-13,785
| -71% | -$874K | 0.03% | 481 |
|
|
2022
Q2 | $1.02M | Buy |
19,545
+1,025
| +6% | +$58.3K | 0.07% | 264 |
|
|
2022
Q1 | $1.05M | Buy |
18,520
+1,019
| +6% | +$54.6K | 0.06% | 279 |
|
|
2021
Q4 | $901K | Buy |
17,501
+816
| +5% | +$40K | 0.06% | 308 |
|
|
2021
Q3 | $826K | Buy |
16,685
+1,778
| +12% | +$96.5K | 0.05% | 315 |
|
|
2021
Q2 | $851K | Buy |
14,907
+472
| +3% | +$27.6K | 0.06% | 293 |
|
|
2021
Q1 | $873K | Buy |
+14,435
| New | +$797K | 0.07% | 269 |
|
|
2019
Q2 | – | Sell |
-4,491
| Closed | -$215K | – | 557 |
|
|
2019
Q1 | $215K | Buy |
+4,491
| New | +$225K | 0.03% | 471 |
|
|
2018
Q4 | – | Sell |
-5,081
| Closed | -$274K | – | 514 |
|
|
2018
Q3 | $274K | Hold |
5,081
| – | – | 0.03% | 444 |
|
|
2018
Q2 | $249K | Sell |
5,081
-300
| -6% | -$17K | 0.03% | 467 |
|
|
2018
Q1 | $337K | Buy |
5,381
+200
| +4% | +$13.7K | 0.04% | 403 |
|
|
2017
Q4 | $315K | Sell |
5,181
-10,736
| -67% | -$664K | 0.04% | 402 |
|
|
2017
Q3 | $1.06M | Buy |
15,917
+166
| +1% | +$11.7K | 0.15% | 156 |
|
|
2017
Q2 | $1.23M | Buy |
15,751
+8,445
| +116% | +$637K | 0.2% | 131 |
|
|
2017
Q1 | $591K | Buy |
7,306
+317
| +5% | +$25K | 0.1% | 243 |
|
|
2016
Q4 | $506K | Sell |
6,989
-494
| -7% | -$35.7K | 0.08% | 281 |
|
|
2016
Q3 | $582K | Buy |
7,483
+756
| +11% | +$61.1K | 0.1% | 242 |
|
|
2016
Q2 | $525K | Sell |
6,727
-25
| -0.4% | -$1.99K | 0.09% | 259 |
|
|
2016
Q1 | $553K | Buy |
6,752
+25
| +0.4% | +$2.03K | 0.1% | 238 |
|
|
2015
Q4 | $600K | Sell |
6,727
-1,375
| -17% | -$117K | 0.11% | 225 |
|
|
2015
Q3 | $624K | Buy |
8,102
+355
| +5% | +$29.7K | 0.12% | 226 |
|
|
2015
Q2 | $647K | Buy |
7,747
+1,105
| +17% | +$97.6K | 0.11% | 238 |
|
|
2015
Q1 | $600K | Buy |
6,642
+58
| +0.9% | +$4.99K | 0.1% | 239 |
|
|
2014
Q4 | $531K | Buy |
6,584
+1,605
| +32% | +$127K | 0.09% | 253 |
|
|
2014
Q3 | $372K | Hold |
4,979
| – | – | 0.06% | 326 |
|
|
2014
Q2 | $341K | Buy |
+4,979
| New | +$339K | 0.06% | 347 |
|
Other funds holding CAH
VCM
VPM
Moors & Cabot's CAH Position: Q1 2026 in Review
Moors & Cabot held its Cardinal Health (CAH) position steady in Q1 2026 at 1,161 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #792.
Moors & Cabot first reported a position in CAH in Q2 2014 and has held it in 40 quarters since. The position peaked at $1.23M in Q2 2017. 1,430 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Moors & Cabot held 1,161 shares of Cardinal Health worth $245K as of Q1 2026.
- Moors & Cabot left its Cardinal Health share count unchanged in Q1 2026.
- Cardinal Health made up 0.01% of Moors & Cabot's portfolio in Q1 2026, its #792 holding.
- Moors & Cabot first reported a position in Cardinal Health in Q2 2014 and has held it in 40 quarters since.
- Moors & Cabot's Cardinal Health position peaked at $1.23M in Q2 2017.
- 1,430 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.